Fragrance or foolery: 15 big drug events will resolve before April
This article was originally published in Scrip
There are 15 big drug development decisions to be taken before April 1, seven of those in the hands of regulatory agencies in the US and Europe. The rest are dependent on clinical data, and some of the companies involved almost certainly already know which way the results going. All of which leaves 14 companies' senior management teams (Sanofi's has two clinical trials to ponder) wondering whether they will feel like bunches of April flowers, or bunches of fools.